- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Development of nasal HPV vaccine formulations ; volume:02 ; number:S 01 ; year:2016 ; 01
Konferenz: 16th Annual International Conference RGCON; 2017-02-03; Habitat World, India habitat Centre, Delhi
Asian Journal of Oncology ; 02, Heft S 01 (2016), 01
- Beteiligte Personen und Organisationen
-
Krishnakumar, D.
Jaganathan, K. S.
- DOI
-
10.1055/s-0039-1685403
- URN
-
urn:nbn:de:101:1-2019090911101035343130
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Krishnakumar, D.
- Jaganathan, K. S.
Ähnliche Objekte (12)
Perspectives for therapeutic HPV vaccine development
Development of vaccine formulations: past, present, and future
Stabilisation and characterisation of protein and vaccine formulations
Stabilisation and characterisation of protein and vaccine formulations
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Effects of excipients in nasal powder formulations for systemic drug delivery
Individual- and Regional-level determinants of Human Papillomavirus (HPV) vaccine refusal: the Ontario Grade 8 HPV vaccine cohort study
Disparities in HPV vaccine knowledge and adolescent HPV vaccine uptake by parental nativity among diverse multiethnic parents in New Jersey
Nasal Powder Formulations : In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects
In-depth immunological analysis of prototypic adjuvants for vaccine formulations
Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice
Meta-analysis of correlates of HPV vaccine acceptability among men: supporting vaccine implementation science
Perspectives for therapeutic HPV vaccine development
Development of vaccine formulations: past, present, and future
Stabilisation and characterisation of protein and vaccine formulations
Stabilisation and characterisation of protein and vaccine formulations
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Effects of excipients in nasal powder formulations for systemic drug delivery
Individual- and Regional-level determinants of Human Papillomavirus (HPV) vaccine refusal: the Ontario Grade 8 HPV vaccine cohort study
Disparities in HPV vaccine knowledge and adolescent HPV vaccine uptake by parental nativity among diverse multiethnic parents in New Jersey
Nasal Powder Formulations : In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects
In-depth immunological analysis of prototypic adjuvants for vaccine formulations
Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice
Meta-analysis of correlates of HPV vaccine acceptability among men: supporting vaccine implementation science
Perspectives for therapeutic HPV vaccine development
Development of vaccine formulations: past, present, and future
Stabilisation and characterisation of protein and vaccine formulations
Stabilisation and characterisation of protein and vaccine formulations
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Effects of excipients in nasal powder formulations for systemic drug delivery
Individual- and Regional-level determinants of Human Papillomavirus (HPV) vaccine refusal: the Ontario Grade 8 HPV vaccine cohort study
Disparities in HPV vaccine knowledge and adolescent HPV vaccine uptake by parental nativity among diverse multiethnic parents in New Jersey
Nasal Powder Formulations : In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects
In-depth immunological analysis of prototypic adjuvants for vaccine formulations
Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice